Latest news and articles about Anew Labs
Total: 1 articles found
ByteDance is spinning off its AI drug discovery unit into an independent entity to bridge the gap between high-speed internet culture and the slow-burn reality of pharmaceutical R&D. Despite technical breakthroughs in undruggable targets, the move reflects a strategic shift toward seeking external capital to fund long-cycle biotech ventures.
